Wade MR: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
|institution=Eli Lilly and Co. | |institution=Eli Lilly and Co. | ||
Lilly Corporate Center/DC0545 | Lilly Corporate Center/DC0545 | ||
|address=893 S Deleware | |address=893 S Deleware | ||
|area code=46285 | |area code=46285 | ||
| Line 13: | Line 13: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at== | == Participated at == | ||
* [[MiPNet20.05 IOC104 Greenville |IOC104 Greenville]] | |||
* [[IOC104]] | * [[IOC104]] | ||
Revision as of 13:42, 18 August 2015
| Name | Wade Mark, |
|---|---|
| Institution | Eli Lilly and Co.
Lilly Corporate Center/DC0545 |
| Address | 893 S Deleware, 46285 |
| City | Indianapolis |
| State/Province | Indiana (IN) |
| Country | USA |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | US IN Indianapolis Brozinick JT |
Labels:
Publications
Add references to your publications
